Central regions | Finance, business

Russian biomed firm ready to sell antibodies to Europe

23 Jul '15
PrimeBioMed, an innovative Russian company, is ready to start exporting to the West its new antibodies to diagnose tumors, reported RVC, Russias fund of funds for innovation.

This has been made possible after this RVC portfolio company completed earlier this summer its ISO 13485 international standard certification procedure. The audit was conducted by Germanys BSI Group Deutschland GmbH. PrimeBioMeds certificate is valid for three years.

The companys plans for later this year and next year include the commercialization of its products internationally. PrimeBioMed is reported to be currently in talks over partnerships with medical centers in Italy and Switzerland.

PrimeBioMed has been in Russias biomed business for less than a year.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
Find Related Content


Latest News: Central regions
23 Apr '18 | Finance, business | Technology & innovation
18 Apr '18 | Technology & innovation
17 Apr '18 | Finance, business | Retail, FMCG
13 Apr '18 | Finance, business | Technology & innovation
11 Apr '18 | Finance, business | Technology & innovation

Feature stories

3 Apr '18
In regions most of European Russians will hardly ever...
21 Nov '17
Russian scientists have come up with what they say is...
7 Sep '17
Search (News archive - 21229)
Independent Software Developers Forum
Marchmont News

Latest News

23 Apr '18
Two experienced Russian companies, MTT and...
20 Apr '18
A special business incubator opened earlier this...
19 Apr '18
Scientists in Samara have come up with a new method...

Most read stories from last week

23 Apr '18
Two experienced Russian companies, MTT and...